Related Experiment Video

Updated: Jun 16, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

BRCA1 represses amphiregulin gene expression

Ekaterina P Lamber1, Andrew A Horwitz, Jeffrey D Parvin

  • 1Department of Pathology, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA.

Cancer Research
|January 28, 2010
PubMed

Insights

BRCA1 loss of function increases amphiregulin (AREG) protein levels by upregulating its transcription. This study identifies direct BRCA1 regulation of AREG, a key finding in breast cancer development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • BRCA1 is a tumor suppressor gene critical for preventing breast and ovarian cancers.
  • BRCA1's function can be context-dependent, acting as either a transcriptional repressor or activator.
  • Dysregulation of BRCA1 is implicated in various cancer pathologies.

Purpose of the Study:

  • To identify genes transcriptionally regulated by BRCA1.
  • To elucidate the mechanism of BRCA1-mediated transcriptional repression, specifically focusing on amphiregulin (AREG).
  • To establish a link between BRCA1 dysfunction and AREG upregulation in breast cancer.

Main Methods:

  • Microarray analysis of cells with depleted BRCA1 to identify regulated genes.
  • Chromatin immunoprecipitation (ChIP) assays to detect BRCA1 binding to target gene promoters.
  • Identification and mapping of BRCA1 response elements (BRREs) on the AREG promoter.

Main Results:

  • BRCA1 depletion led to the upregulation of specific genes, including amphiregulin (AREG) and early growth response-1 (EGR1).
  • BRCA1 directly binds to the AREG promoter, indicating direct transcriptional repression.
  • Two distinct BRCA1 response elements were identified on the AREG promoter, crucial for BRCA1-mediated repression.
  • BRCA1 depletion resulted in increased AREG protein levels.

Conclusions:

  • Loss of BRCA1 function leads to the upregulation of AREG transcription and protein.
  • BRCA1 directly represses AREG gene expression through specific promoter elements.
  • The identified BRCA1-AREG regulatory pathway is frequently altered in breast cancer, highlighting its potential role in tumorigenesis.

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA108:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...